BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 16309621)

  • 1. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry.
    Davies SS; Zackert W; Luo Y; Cunningham CC; Frisard M; Roberts LJ
    Anal Biochem; 2006 Jan; 348(2):185-91. PubMed ID: 16309621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay.
    Morrow JD; Zackert WE; Yang JP; Kurhts EH; Callewaert D; Dworski R; Kanai K; Taber D; Moore K; Oates JA; Roberts LJ
    Anal Biochem; 1999 May; 269(2):326-31. PubMed ID: 10222005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay.
    Morales CR; Terry ES; Zackert WE; Montine TJ; Morrow JD
    Clin Chim Acta; 2001 Dec; 314(1-2):93-9. PubMed ID: 11718683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of 8-epi PGF(2alpha) concentrations as a biomarker of oxidative stress using triple-stage liquid chromatography/tandem mass spectrometry.
    Bastani NE; Gundersen TE; Blomhoff R
    Rapid Commun Mass Spectrom; 2009 Sep; 23(18):2885-90. PubMed ID: 19670343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry.
    Mori TA; Croft KD; Puddey IB; Beilin LJ
    Anal Biochem; 1999 Mar; 268(1):117-25. PubMed ID: 10036170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of prolonged gradient separation for high-performance liquid chromatography-tandem mass spectrometry quantitation of plasma total 15-series F-isoprostanes.
    Taylor AW; Bruno RS; Frei B; Traber MG
    Anal Biochem; 2006 Mar; 350(1):41-51. PubMed ID: 16448621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of urinary 8-iso-PGF2alpha using liquid chromatography-tandem mass spectrometry and association with elevated troponin levels.
    Saenger AK; Laha TJ; Edenfield MJ; Sadrzadeh SM
    Clin Biochem; 2007 Nov; 40(16-17):1297-304. PubMed ID: 17854792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography/mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane.
    Il'yasova D; Morrow JD; Ivanova A; Wagenknecht LE
    Ann Epidemiol; 2004 Nov; 14(10):793-7. PubMed ID: 15519902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha).
    Dworski R; Roberts LJ; Murray JJ; Morrow JD; Hartert TV; Sheller JR
    Clin Exp Allergy; 2001 Mar; 31(3):387-90. PubMed ID: 11260149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary 8-epi-PGF2alpha and its endogenous beta-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress.
    Nourooz-Zadeh J; Cooper MB; Ziegler D; Betteridge DJ
    Biochem Biophys Res Commun; 2005 May; 330(3):731-6. PubMed ID: 15809058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans.
    Schweer H; Watzer B; Seyberth HW; Nüsing RM
    J Mass Spectrom; 1997 Dec; 32(12):1362-70. PubMed ID: 9423285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of an on-line two-dimensional reversed-phase liquid chromatography-tandem mass spectrometry method for the simultaneous determination of prostaglandins E(2) and F(2alpha) and 13,14-dihydro-15-keto prostaglandin F(2alpha) levels in human plasma.
    Komaba J; Matsuda D; Shibakawa K; Nakade S; Hashimoto Y; Miyata Y; Ogawa M
    Biomed Chromatogr; 2009 Mar; 23(3):315-23. PubMed ID: 18800333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of urinary excretion of 1,N6-ethenoadenine, a potential biomarker of lipid peroxidation, in humans by stable isotope dilution liquid chromatography-electrospray ionization-tandem mass spectrometry: comparison with gas chromatography-mass spectrometry.
    Chen HJ; Chang CM
    Chem Res Toxicol; 2004 Jul; 17(7):963-71. PubMed ID: 15257622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of F2-isoprostanes in urine by online solid phase extraction coupled to liquid chromatography with tandem mass spectrometry.
    Langhorst ML; Hastings MJ; Yokoyama WH; Hung SC; Cellar N; Kuppannan K; Young SA
    J Agric Food Chem; 2010 Jun; 58(11):6614-20. PubMed ID: 20476785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergence in urinary 8-iso-PGF(2alpha) (iPF(2alpha)-III, 15-F(2t)-IsoP) levels from gas chromatography-tandem mass spectrometry quantification after thin-layer chromatography and immunoaffinity column chromatography reveals heterogeneity of 8-iso-PGF(2alpha). Possible methodological, mechanistic and clinical implications.
    Tsikas D; Schwedhelm E; Suchy MT; Niemann J; Gutzki FM; Erpenbeck VJ; Hohlfeld JM; Surdacki A; Frölich JC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Sep; 794(2):237-55. PubMed ID: 12954376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tandem mass spectrometric quantification of 8-iso-prostaglandin F2alpha and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2alpha in human urine.
    Schwedhelm E; Tsikas D; Durand T; Gutzki FM; Guy A; Rossi JC; Frölich JC
    J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(1):99-112. PubMed ID: 10985571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry.
    Liang Y; Wei P; Duke RW; Reaven PD; Harman SM; Cutler RG; Heward CB
    Free Radic Biol Med; 2003 Feb; 34(4):409-18. PubMed ID: 12566066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of urinary F(2)-isoprostanes by gas chromatography-mass spectrometry is confounded by interfering substances.
    Mas E; Barden A; Durand T; Galano JM; Croft KD; Mori TA
    Free Radic Res; 2010 Feb; 44(2):191-8. PubMed ID: 19929242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women and smokers have elevated urinary F(2)-isoprostane metabolites: a novel extraction and LC-MS methodology.
    Taylor AW; Bruno RS; Traber MG
    Lipids; 2008 Oct; 43(10):925-36. PubMed ID: 18751751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous quantification of 8-iso-prostaglandin-F(2alpha) and 11-dehydro thromboxane B(2) in human urine by liquid chromatography-tandem mass spectrometry.
    Cavalca V; Minardi F; Scurati S; Guidugli F; Squellerio I; Veglia F; Dainese L; Guarino A; Tremoli E; Caruso D
    Anal Biochem; 2010 Feb; 397(2):168-74. PubMed ID: 19825360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.